Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
Avadel Pharmaceuticals Cash from Operations (TTM) : 37.01M for Sept. 30, 2025
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2025 | 37.01M |
| June 30, 2025 | 6.095M |
| March 31, 2025 | -24.77M |
| December 31, 2024 | -46.24M |
| September 30, 2024 | -81.98M |
| June 30, 2024 | -112.78M |
| March 31, 2024 | -131.64M |
| December 31, 2023 | -132.17M |
| September 30, 2023 | -122.15M |
| June 30, 2023 | -88.41M |
| March 31, 2023 | -69.09M |
| December 31, 2022 | -72.90M |
| September 30, 2022 | -77.13M |
| June 30, 2022 | -92.76M |
| March 31, 2022 | -85.39M |
| December 31, 2021 | -74.76M |
| September 30, 2021 | -74.05M |
| June 30, 2021 | -65.13M |
| March 31, 2021 | -62.74M |
| December 31, 2020 | -50.97M |
| September 30, 2020 | -39.02M |
| June 30, 2020 | -34.79M |
| March 31, 2020 | -28.34M |
| December 31, 2019 | -37.91M |
| September 30, 2019 | -52.97M |
| Date | Value |
|---|---|
| June 30, 2019 | -65.18M |
| March 31, 2019 | -83.20M |
| December 31, 2018 | -80.00M |
| September 30, 2018 | -71.73M |
| June 30, 2018 | -54.07M |
| March 31, 2018 | -25.92M |
| December 31, 2017 | 17.39M |
| September 30, 2017 | 39.58M |
| June 30, 2017 | 36.40M |
| March 31, 2017 | 23.35M |
| December 31, 2016 | 18.41M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 17.67M |
| December 31, 2014 | -9.999M |
| September 30, 2014 | -11.77M |
| June 30, 2014 | -15.62M |
| March 31, 2014 | -16.00M |
| December 31, 2013 | -21.20M |
| September 30, 2013 | |
| June 30, 2013 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Jazz Pharmaceuticals Plc | 1.661B |
| Perrigo Co. Plc | 196.10M |
| GH Research Plc | -52.32M |
| Cosmo NV | -23.86M |
| Alkermes Plc | 251.18M |